HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis

Yap, C.F. orcid.org/0000-0001-5256-5642, Nair, N., de Vries, A. et al. (7 more authors) (2024) HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 83 (2). pp. 263-265. ISSN 0003-4967

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Keywords: Adalimumab; Autoantibodies; Methotrexate; Arthritis, Rheumatoid
Dates:
  • Accepted: 22 July 2023
  • Published (online): 12 September 2023
  • Published: February 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Funding Information:
FunderGrant number
NIHR National Inst Health ResearchBRC
MRC (Medical Research Council)R116825
NIHR National Inst Health ResearchNIHR202395
Depositing User: Symplectic Publications
Date Deposited: 22 Jan 2024 14:22
Last Modified: 22 Jan 2024 14:22
Status: Published
Publisher: BMJ
Identification Number: https://doi.org/10.1136/ard-2023-223955
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)